Summary
Contents
Subject index
With escalating healthcare costs, changes to the regulatory control on pharmaceutical industries and the inevitable adjustments made in policies and investment in healthcare there is enormous interest in the commercial as well as the scientific aspects of today's healthcare industry.
The SAGE Handbook of Healthcare provides an authoritative analysis of the current (and anticipated) developments in the global healthcare industries. Providing a unique perspective that interfaces between the science and business aspects, it combines information on the latest scientific developments with applied, commercial business data from the global marketplace.
The Handbook focuses on the aspects of paramount importance in the healthcare sector: Pharmacoeconomics; Pharmacogenomics; Therapeutics; Diagnostics
Areas covered include: The role of nanotechnology, genomics and cell therapy in medicine; Diagnostics; Biomarkers and technological advances; Case studies in oncology and cardiovascular and CNS therapeutics
Has Genomics Failed to Deliver?
Has Genomics Failed to Deliver?
The Early Promise of Genomics
By 2000, the human genome had largely been sequenced, and by 2001, the first human genome map had been generated. The science and medical communities were very excited about the possibility of thousands of new genomics-derived drugs entering product development pipelines.
One of the key goals of early ...
- Loading...